A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples, JIC, 2022
明石祐作先生（筆頭および責任著者）
https://www.sciencedirect.com/science/article/pii/S1341321X22000642
・鼻腔の抗原定性検査について、鼻咽頭のRT-PCR法（感染研）を基準検査法として、前向き評価：800検体（陽性110検体）
・感度72.7%, 特異度100% (鼻腔PCRは86.4%)
有症状患者：84.7%の感度
Abstract
Introduction
The diagnostic accuracy of antigen testing of anterior nasal (AN) samples for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been evaluated in the Japanese population. This study assessed the diagnostic accuracy of the Roche SARS-CoV-2 rapid antigen test (rapid antigen test) using AN samples.
Methods
Two AN samples and one nasopharyngeal (NP) sample were collected from individuals undergoing screening for SARS-CoV-2 infection. The results of the rapid antigen test and the reverse-transcription polymerase chain reaction (RT-PCR) test using AN samples were compared to those of RT-PCR tests using NP samples.
Results
Samples were collected from 800 participants, 95 and 110 of whom tested positive for SARS-CoV-2 on RT-PCR tests of AN and NP samples, respectively. The overall sensitivity/specificity of the AN rapid antigen test and AN RT-PCR were 72.7%/100% and 86.4%/100%, respectively. In symptomatic cases, the sensitivities of the AN rapid antigen test and AN RT-PCR were 84.7% and 94.9%, respectively. In asymptomatic cases, the sensitivities of the AN rapid antigen test and AN RT-PCR were 58.8% and 76.5%, respectively. The sensitivity of the AN rapid antigen test was over 80% in cases with cycle threshold (Ct) values
Conclusion
The rapid antigen test with AN samples had a favorable sensitivity, especially in symptomatic cases or in cases with Ct values
Keywords
SARS-CoV-2COVID-19Rapid antigen testAnterior nasal sampleDiagnostic performance study
